China Traditional Chinese Medicine Holdings Co (China Traditional Chinese Medicine Holdings Co) Cash-to-Debt : 0.76 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. China Traditional Chinese Medicine Holdings Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.76.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, China Traditional Chinese Medicine Holdings Co couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for China Traditional Chinese Medicine Holdings Co's Cash-to-Debt or its related term are showing as below:

CHIZF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.38 Med: 0.85 Max: 1.18
Current: 0.76

During the past 13 years, China Traditional Chinese Medicine Holdings Co's highest Cash to Debt Ratio was 1.18. The lowest was 0.38. And the median was 0.85.

CHIZF's Cash-to-Debt is ranked worse than
54.35% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs CHIZF: 0.76

China Traditional Chinese Medicine Holdings Co Cash-to-Debt Historical Data

The historical data trend for China Traditional Chinese Medicine Holdings Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

China Traditional Chinese Medicine Holdings Co Cash-to-Debt Chart

China Traditional Chinese Medicine Holdings Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

1.18

0.96

0.82

0.73

0.76

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.82	0.84	0.73	0.68	0.76

Competitive Comparison of China Traditional Chinese Medicine Holdings Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Traditional Chinese Medicine Holdings Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Traditional Chinese Medicine Holdings Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where China Traditional Chinese Medicine Holdings Co's Cash-to-Debt falls into.

China Traditional Chinese Medicine Holdings Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

China Traditional Chinese Medicine Holdings Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	546.777	/	(415.862	+	306.825)
	=	0.76

China Traditional Chinese Medicine Holdings Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	546.777	/	(415.862	+	306.825)
	=	0.76

China Traditional Chinese Medicine Holdings Co (OTCPK:CHIZF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

China Traditional Chinese Medicine Holdings Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

China Traditional Chinese Medicine Holdings Co (China Traditional Chinese Medicine Holdings Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (OTCPK:CHIZF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

00570:Hong Kong WSG:Germany

Address

288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG

Website

https://www.china-tcm.com.cn

China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through five segments, finished drugs; concentrated TCM granules; TCM decoction pieces; TCM healthcare complex, and Local TCM integrated operation. It generates maximum revenue from the concentrated TCM granules segment. Geographically, it derives a majority of its revenue from Mainland China.